Unknown

Dataset Information

0

Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8+CD11c+ Cell Accumulation.


ABSTRACT: Conventional DNA vaccine strategies usually employ a regimen of immunizations at 2-week or longer intervals to induce effective memory cell-dependent immune responses. Clinical cancer treatment requires a faster immunization strategy to contend with tumor progression. In this study, a novel fast immunization strategy was established, wherein a DNA vaccine was intramuscularly administered on days 0, 2, and 5 in a murine lung cancer model. Effector cells peaked 7 to 10 days after the last vaccination. Compared with traditional 2-week-interval immunization strategies, antigen-specific cytolysis and INF-γ secretion were significantly enhanced under the fast vaccination approach. As a result, the rapidly administered DNA vaccine elicited stronger and more prompt antitumor effects. The probable underlying mechanism of fast immunization was the accumulation of CD8+CD11c+ antigen-presenting cells at the injection site, which enhanced subsequent antigen presentation. In conclusion, the fast DNA vaccination strategy shortened vaccination time to 5 days and elicited a stronger antitumor immune response.

SUBMITTER: Liu C 

PROVIDER: S-EPMC8691261 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Fast DNA Vaccination Strategy Elicits a Stronger Immune Response Dependent on CD8<sup>+</sup>CD11c<sup>+</sup> Cell Accumulation.

Liu Chenlu C   Cong Xianling X   Wang Yuqian Y   Guo Qianqian Q   Xie Yu Y   Geng Fei F   Guo Jie J   Dong Ling L   Zhou Yi Y   Wu Hui H   Yu Bin B   Wu Jiaxin J   Zhang Haihong H   Yu Xianghui X   Kong Wei W  

Frontiers in oncology 20211207


Conventional DNA vaccine strategies usually employ a regimen of immunizations at 2-week or longer intervals to induce effective memory cell-dependent immune responses. Clinical cancer treatment requires a faster immunization strategy to contend with tumor progression. In this study, a novel fast immunization strategy was established, wherein a DNA vaccine was intramuscularly administered on days 0, 2, and 5 in a murine lung cancer model. Effector cells peaked 7 to 10 days after the last vaccinat  ...[more]

Similar Datasets

| S-EPMC5087309 | biostudies-literature
| S-EPMC5181791 | biostudies-literature
| S-EPMC10369267 | biostudies-literature
| S-EPMC6391875 | biostudies-literature
| S-EPMC8554207 | biostudies-literature
| S-EPMC8299994 | biostudies-literature
| S-EPMC10510741 | biostudies-literature
| S-EPMC7928063 | biostudies-literature
| S-EPMC8577586 | biostudies-literature
| S-EPMC8674882 | biostudies-literature